Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Michael Fitzgerald Joins Cowen’s Prime Services Sales Team
-
Companies with NDRs 6/30
-
Mereo BioPharma Strengthens Management Team; Appoints John Lewicki, PhD, as Chief Scientific Officer and Ann Kapoun, PhD, as SVP of Translational Research and Development
-
Mereo BioPharma Strengthens Management Team; Appoints John Lewicki, PhD, as Chief Scientific Officer and Ann Kapoun, PhD, as SVP of Translational Research and Development
-
Heron Therapeutics (HRTX) PT Lowered to $26 at Cantor Fitzgerald, After Receiving Complete Response Letter for HTX-011
-
Insurance Acquisition Corp. (INSU) to Combine with Shift Technologies
-
Shift Technologies and Insurance Acquisition Corp. Combine to Bring to the Public Markets the Newest Pure-Play in the Used Car Auto Ecommerce Market
-
Companies with NDRs 6/29
-
Aesthetic Medical Intl. (AIH) PT Lowered to $9 at Cantor Fitzgerald
-
Soliton (SOLY) Prices 4.22M Share Common Offering at $8.30/Sh
-
Soliton Announces Pricing of Public Offering
-
UPDATE: Inovio Pharmaceuticals (INO) PT Raised to $45 at Cantor Fitzgerald
-
Companies with NDRs 6/26
-
Fusion Acquisition Corp. (FUSE) Prices 30.5M Unit IPO at $10/Unit
-
Aridis Pharmaceuticals to Participate in Cantor Fitzgerald Virtual Symposium: Winning Ways to Treat Infections and COVID-19
-
Fusion Acquisition Corp. Announces Pricing of $305 Million Initial Public Offering
-
Soliton (SOLY) Announces Proposed Common Share Offering
-
Soliton Announces Proposed Public Offering of Common Stock
-
Acreage Holdings Inc. (ACRG/U:CN) (ACRGF) PT Lowered to $2.30 at Cantor Fitzgerald
-
Companies with NDRs 6/25
-
Companies with NDRs 6/24
-
Metalla and Coeur Announce Increase in Secondary Bought Deal Offering of Common Shares of Metalla to US$18 Million
-
Pre-Open Stock Movers 06/23: (TBIO) (APYX) (PTN) Higher; (SNSS) (SINT) (LK) Lower (more...)
-
Paramount Gold Nevada Prices Registered Direct Offering and Concurrent Best Efforts Offering in Canada
-
Cidara Therapeutics to Participate in Cantor Fitzgerald Virtual Symposium: Winning Ways to Treat Infections and COVID-19
-
Cidara Therapeutics to Participate in Cantor Fitzgerald Virtual Symposium: Winning Ways to Treat Infections and COVID-19
-
Companies with NDRs 6/23
-
After-Hours Stock Movers 06/22: (APYX) (AGTC) (MYOV) Higher; (ONEM) (TMUS) Lower (more...)
-
Paramount Gold Nevada Corp (PZG) Announces Registered Direct Offering and Concurrent Best Efforts Placement in Canada
-
Paramount Gold Nevada Announces Registered Direct Offering and Concurrent Best Efforts Placement in Canada
-
Paramount Gold Nevada Announces Registered Direct Offering and Concurrent Best Efforts Placement in Canada
-
Metalla Royalty & Streaming (MTA) Announces 2.4M Secondary Offering by Selling Shareholder Coeur Mining (CDE) at $5.30/Sh
-
Metalla and Coeur Announce US$12.7 Million Secondary Bought Deal Offering of Common Shares of Metalla
-
Metalla and Coeur Announce US$12.7 Million Secondary Bought Deal Offering of Common Shares of Metalla
-
Cantor Fitzgerald Starts Applied Genetic Technologies Corp. (AGTC) at Overweight
-
Provention Bio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Companies with NDRs 6/22
-
AAC Holdings Gains Support From Lenders, Proceeds With Recapitalization Plan to Support Patient Care & Long-Term Growth
-
AAC Holdings Gains Support From Lenders, Proceeds With Recapitalization Plan to Support Patient Care & Long-Term Growth
-
Companies with NDRs 6/19
-
Celldex Therapeutics Announces Closing of $150.0 Million Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Provention Bio Inc. (PRVB) Prices 6.6M Share Common Offering at $14.50/Sh
-
Aridis Pharmaceuticals to Discuss APEX™ in Virtual Fireside Chat Hosted by Cantor Fitzgerald on June 25th
-
Rexahn and Ocuphire Enter into Definitive Merger Agreement
-
Provention Bio Announces Pricing of $95.7 Million Public Offering of Common Stock
-
KBRA Assigns Issuer Rating of BBB to Cantor Fitzgerald, L.P.
-
Benefytt Technologies (BFYT) Shares Remain Cheap - Cantor Fitzgerald
-
Companies with NDRs 6/17
-
Humana (HUM) PT Raised to $410 at Cantor Fitzgerald
-
Orchid Island Capital Announces June 2020 Monthly Dividend and May 31, 2020 RMBS Portfolio Characteristics

